XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2020   56,774,294      
Beginning balance at Dec. 31, 2020 $ 541.0 $ 0.0 $ 859.8 $ (320.6) $ 1.8
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units(in shares)   577,162      
Exercise of stock options and distribution of restricted stock units 6.1   6.1    
Issuance of common stock (in shares)   4,018,647      
Issuance of common stock 640.3   640.3    
Stock-based compensation 6.1   6.1    
Net loss (49.0)     (49.0)  
Other comprehensive income (loss) (0.8)       (0.8)
Ending balance (in shares) at Mar. 31, 2021   61,370,103      
Ending balance at Mar. 31, 2021 1,143.7 $ 0.0 1,512.3 (369.6) 1.0
Beginning balance (in shares) at Dec. 31, 2020   56,774,294      
Beginning balance at Dec. 31, 2020 541.0 $ 0.0 859.8 (320.6) 1.8
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Net loss (171.0)        
Ending balance (in shares) at Sep. 30, 2021   61,615,624      
Ending balance at Sep. 30, 2021 1,048.0 $ 0.0 1,539.5 (491.6) 0.1
Beginning balance (in shares) at Mar. 31, 2021   61,370,103      
Beginning balance at Mar. 31, 2021 1,143.7 $ 0.0 1,512.3 (369.6) 1.0
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units(in shares)   162,024      
Exercise of stock options and distribution of restricted stock units 1.7   1.7    
Stock-based compensation 11.9   11.9    
Net loss (55.6)     (55.6)  
Other comprehensive income (loss) (0.1)       (0.1)
Ending balance (in shares) at Jun. 30, 2021   61,532,127      
Ending balance at Jun. 30, 2021 1,101.6 $ 0.0 1,525.9 (425.2) 0.9
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units(in shares)   83,497      
Exercise of stock options and distribution of restricted stock units 0.9   0.9    
Stock-based compensation 12.7   12.7    
Net loss (66.4)     (66.4)  
Other comprehensive income (loss) (0.8)       (0.8)
Ending balance (in shares) at Sep. 30, 2021   61,615,624      
Ending balance at Sep. 30, 2021 $ 1,048.0 $ 0.0 1,539.5 (491.6) 0.1
Beginning balance (in shares) at Dec. 31, 2021 61,660,996 61,660,996      
Beginning balance at Dec. 31, 2021 $ 988.2 $ 0.0 1,553.5 (561.9) (3.4)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units(in shares)   97,743      
Exercise of stock options and distribution of restricted stock units 0.6   0.6    
Stock-based compensation 14.1   14.1    
Net loss (74.8)     (74.8)  
Other comprehensive income (loss) (15.4)       (15.4)
Ending balance (in shares) at Mar. 31, 2022   61,758,739      
Ending balance at Mar. 31, 2022 $ 912.7 $ 0.0 1,568.2 (636.7) (18.8)
Beginning balance (in shares) at Dec. 31, 2021 61,660,996 61,660,996      
Beginning balance at Dec. 31, 2021 $ 988.2 $ 0.0 1,553.5 (561.9) (3.4)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units(in shares) 404,133        
Net loss $ (234.1)        
Ending balance (in shares) at Sep. 30, 2022 69,120,346 69,120,346      
Ending balance at Sep. 30, 2022 $ 906.8 $ 0.0 1,738.1 (796.0) (35.3)
Beginning balance (in shares) at Mar. 31, 2022   61,758,739      
Beginning balance at Mar. 31, 2022 912.7 $ 0.0 1,568.2 (636.7) (18.8)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options and distribution of restricted stock units(in shares)   108,838      
Exercise of stock options and distribution of restricted stock units 0.4   0.4    
Stock-based compensation 13.9   13.9    
Net loss (67.9)     (67.9)  
Other comprehensive income (loss) (10.0)       (10.0)
Ending balance (in shares) at Jun. 30, 2022   61,867,577      
Ending balance at Jun. 30, 2022 849.1 $ 0.0 1,582.5 (704.6) (28.8)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Issuances of common stock from acquisition of Metromile(in shares)   6,901,934      
Issuance of common stock from acquisition of Metromile (Note 5) 137.7   137.7    
Exercise of stock options and distribution of restricted stock units(in shares)   350,835      
Exercise of stock options and distribution of restricted stock units 2.3   2.3    
Stock-based compensation 15.6   15.6    
Net loss (91.4)     (91.4)  
Other comprehensive income (loss) $ (6.5)       (6.5)
Ending balance (in shares) at Sep. 30, 2022 69,120,346 69,120,346      
Ending balance at Sep. 30, 2022 $ 906.8 $ 0.0 $ 1,738.1 $ (796.0) $ (35.3)